Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

NAD+ Metabolism Maintains Inducible PD-L1 Expression to Drive Tumor Immune Evasion
Hongwei Lv, Guishuai Lv, Cian Chen, et al.
Cell Metabolism (2020) Vol. 33, Iss. 1, pp. 110-127.e5
Open Access | Times Cited: 198

Showing 51-75 of 198 citing articles:

Application of Aptamer-SERS Nanotags for Unveiling the PD-L1 Immunomarker Progression Correlated to the Cell Metabolic Bioprocess
Muhammad Muhammad, Changsheng Shao, Mona Alrasheed Bashir, et al.
Analytical Chemistry (2024) Vol. 96, Iss. 16, pp. 6236-6244
Closed Access | Times Cited: 7
NAD+metabolism enzyme NNMT in cancer-associated fibroblasts drives tumor progression and resistance to immunotherapy by modulating macrophages in urothelial bladder cancer
Meihua Yang, Bo Wang, Weibin Hou, et al.
Journal for ImmunoTherapy of Cancer (2024) Vol. 12, Iss. 7, pp. e009281-e009281
Open Access | Times Cited: 7
Mitochondrial respiration contributes to the interferon gamma response in antigen-presenting cells
Michael C Kiritsy, Katelyn McCann, Daniel Mott, et al.
eLife (2021) Vol. 10
Open Access | Times Cited: 35
Extracellular vesicles derived from M2-polarized tumor-associated macrophages promote immune escape in ovarian cancer through NEAT1/miR-101-3p/ZEB1/PD-L1 axis
Lili Yin, Yu Wang
Cancer Immunology Immunotherapy (2022) Vol. 72, Iss. 3, pp. 743-758
Open Access | Times Cited: 26
HSP90 Mediates IFNγ-Induced Adaptive Resistance to Anti-PD-1 Immunotherapy
Ke Liu, Jun Huang, Jiao Liu, et al.
Cancer Research (2022) Vol. 82, Iss. 10, pp. 2003-2018
Open Access | Times Cited: 25
Homotypic Targeted Photosensitive Nanointerferer for Tumor Cell Cycle Arrest to Boost Tumor Photoimmunotherapy
Xue‐Feng Bai, Ying Chen, Mei‐Zhen Zou, et al.
ACS Nano (2022) Vol. 16, Iss. 11, pp. 18555-18567
Closed Access | Times Cited: 23
Targeting ZDHHC9 potentiates anti-programmed death-ligand 1 immunotherapy of pancreatic cancer by modifying the tumor microenvironment
Zhiqing Lin, Keke Huang, Hui Guo, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 161, pp. 114567-114567
Open Access | Times Cited: 16
Supplementation with α-ketoglutarate improved the efficacy of anti-PD1 melanoma treatment through epigenetic modulation of PD-L1
Nian Liu, Jianglin Zhang, Mingjie Yan, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 2
Open Access | Times Cited: 15
Engineering of dendritic cell bispecific extracellular vesicles for tumor-targeting immunotherapy
Fang Xu, Dongpeng Jiang, Jialu Xu, et al.
Cell Reports (2023) Vol. 42, Iss. 10, pp. 113138-113138
Open Access | Times Cited: 15
Comprehensive analysis of nicotinamide metabolism-related signature for predicting prognosis and immunotherapy response in breast cancer
Hanxiao Cui, Xueting Ren, Luyao Dai, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 13
The biological essence of synthetic lethality: Bringing new opportunities for cancer therapy
Meiyi Ge, Jian Luo, Yi Wu, et al.
MedComm – Oncology (2024) Vol. 3, Iss. 1
Open Access | Times Cited: 5
Discovery of Small Molecules Simultaneously Targeting NAD(P)H:Quinone Oxidoreductase 1 and Nicotinamide Phosphoribosyltransferase: Treatment of Drug-Resistant Non-small-Cell Lung Cancer
Kuojun Zhang, Kaizhen Wang, Xiangyu Zhang, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 11, pp. 7746-7769
Closed Access | Times Cited: 22
Irradiation combined with PD-L1−/− and autophagy inhibition enhances the antitumor effect of lung cancer via cGAS-STING-mediated T cell activation
Xinrui Zhao, Songling Hu, Liang Zeng, et al.
iScience (2022) Vol. 25, Iss. 8, pp. 104690-104690
Open Access | Times Cited: 21
N 6 ‐Methyladenosine‐Modified CBX1 Regulates Nasopharyngeal Carcinoma Progression Through Heterochromatin Formation and STAT1 Activation
Yin Zhao, Sheng‐Yan Huang, Xi-Rong Tan, et al.
Advanced Science (2022) Vol. 9, Iss. 36
Open Access | Times Cited: 20
Ketoglutaric acid can reprogram the immunophenotype of triple-negative breast cancer after radiotherapy and improve the therapeutic effect of anti-PD-L1
Hongpei Tan, Jiahao Liu, Jing Huang, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 12
NAD+ supplementation limits triple-negative breast cancer metastasis via SIRT1-P66Shc signaling
Yi Jiang, Zongrui Luo, Yuanchao Gong, et al.
Oncogene (2023) Vol. 42, Iss. 11, pp. 808-824
Closed Access | Times Cited: 11
Evolving Tumor Characteristics and Smart Nanodrugs for Tumor Immunotherapy
Wenshe Sun, Shaowei Xie, Shi Liu, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 3919-3942
Open Access | Times Cited: 4
Cellular Senescence in Tumor Immune Escape: Mechanisms, Implications, and Therapeutic Potential
You Li, Qinghua Wu
Critical Reviews in Oncology/Hematology (2025), pp. 104628-104628
Closed Access
Identification and validation of a prognostic signature of drug resistance and mitochondrial energy metabolism-related differentially expressed genes for breast cancer
Tiankai Xu, Chu Chu, Shuyu Xue, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access
Cellular senescence: from homeostasis to pathological implications and therapeutic strategies
Chunhong Li, Yixiao Yuan, YingDong Jia, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Interactions between NAD+ metabolism and immune cell infiltration in ulcerative colitis: subtype identification and development of novel diagnostic models
Linglin Tian, Huiyang Gao, Yao Tian, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Epigallocatechin‐Gallate: Unraveling Its Protective Mechanisms and Therapeutic Potential
Xinchun Dong, Fang Wei, Yao Li, et al.
Cell Biochemistry and Function (2025) Vol. 43, Iss. 2
Closed Access
Chidamide functions as a VISTA/PSGL-1 blocker for cancer immunotherapy
Xiaoshuang Niu, Wenshan Zhao, Xiuman Zhou, et al.
Cancer Immunology Immunotherapy (2025) Vol. 74, Iss. 3
Open Access
Cryo‐Shocked Tumor‐Reprogrammed Sonosensitive Antigen‐Presenting Cells Improving Sonoimmunotherapy via T Cells and NK Cells Immunity
Xindi Qian, Wenzhe Yi, Wenlu Yan, et al.
Advanced Materials (2025)
Closed Access
Purine metabolism-associated key genes depict the immune landscape in gout patients
Lin-na Li, Hao Wang, Lushan Xiao, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access

Scroll to top